ZA200100976B - Live attenuated salmonella vaccines to control avian pathogens. - Google Patents
Live attenuated salmonella vaccines to control avian pathogens.Info
- Publication number
- ZA200100976B ZA200100976B ZA200100976A ZA200100976A ZA200100976B ZA 200100976 B ZA200100976 B ZA 200100976B ZA 200100976 A ZA200100976 A ZA 200100976A ZA 200100976 A ZA200100976 A ZA 200100976A ZA 200100976 B ZA200100976 B ZA 200100976B
- Authority
- ZA
- South Africa
- Prior art keywords
- live attenuated
- attenuated salmonella
- avian pathogens
- salmonella vaccines
- control avian
- Prior art date
Links
- 241000271566 Aves Species 0.000 title 1
- 241000607142 Salmonella Species 0.000 title 1
- 230000002238 attenuated effect Effects 0.000 title 1
- 244000052769 pathogen Species 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/255—Salmonella (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/544—Mucosal route to the airways
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/122,441 US6399074B1 (en) | 1998-07-24 | 1998-07-24 | Live attenuated salmonella vaccines to control avian pathogens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200100976B true ZA200100976B (en) | 2001-08-13 |
Family
ID=22402731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200100976A ZA200100976B (en) | 1998-07-24 | 2001-02-05 | Live attenuated salmonella vaccines to control avian pathogens. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6399074B1 (xx) |
| EP (1) | EP1100536A2 (xx) |
| JP (1) | JP2002521345A (xx) |
| CN (1) | CN1315871A (xx) |
| AU (1) | AU4991499A (xx) |
| BR (1) | BR9912410A (xx) |
| CA (1) | CA2338555A1 (xx) |
| MX (1) | MXPA01000884A (xx) |
| WO (1) | WO2000004919A2 (xx) |
| ZA (1) | ZA200100976B (xx) |
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6872398B2 (en) * | 1995-12-22 | 2005-03-29 | The United States Of America As Represented By The Secretary Of The Army | Conjugate vaccine against gram-negative bacterial infections |
| US7026155B2 (en) * | 1999-02-02 | 2006-04-11 | Regents Of The University Of California | Method of reducing bacterial proliferation |
| MY128159A (en) * | 2000-06-30 | 2007-01-31 | Wyeth Corp | Methods and composition for oral vaccination |
| CA2442004A1 (en) * | 2001-03-23 | 2002-10-03 | David J. Kyle | Microbial feeds for aquaculture and agriculture |
| EP1499191B1 (en) * | 2002-04-15 | 2012-05-09 | Washington University in St. Louis | Regulated attenuation of live vaccines to enhance cross protective immunogenicity |
| US20050260225A1 (en) * | 2004-05-18 | 2005-11-24 | Goldberg Joanna B | Intranasal recombinant Salmonella vaccine encoding heterologous polysaccharide antigens |
| CN101273133A (zh) * | 2005-08-30 | 2008-09-24 | 联邦科学工业研究组织 | 生物活性多肽的细菌传送 |
| CA2649426C (en) * | 2006-04-17 | 2014-04-01 | Schering-Plough Ltd. | Recombinant attenuated clostridium organisms and vaccine |
| US20080124355A1 (en) | 2006-09-22 | 2008-05-29 | David Gordon Bermudes | Live bacterial vaccines for viral infection prophylaxis or treatment |
| US20080115830A1 (en) * | 2006-11-22 | 2008-05-22 | High Power-Factor Ac/Dc Converter With Parallel Power Processing | Test device for solar concentrator module |
| US20080260777A1 (en) * | 2007-04-19 | 2008-10-23 | Sotomayor Konky | Composition and method for controlling intestinal pathogenic organisms |
| US7935355B2 (en) * | 2007-04-19 | 2011-05-03 | Nutritional Health Institute Laboratories, Llc | Composition and method for controlling intestinal pathogenic organisms |
| WO2009025888A2 (en) | 2007-05-10 | 2009-02-26 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Regulated synthesis of antigen and/or regulated attentuation to enhance vaccine immunogenics and/or safety |
| EP2152883A4 (en) * | 2007-05-10 | 2010-10-27 | Univ Arizona | RECOMBINANT BACTERIA WITH VECTORS FOR THE EXPRESSION OF NUCLEIC ACID SEQUENCES-CODING ANTIGENES |
| US9040059B2 (en) | 2007-10-05 | 2015-05-26 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Recombinant bacterium capable of eliciting a protective immune response against C. perfringens |
| US8647642B2 (en) | 2008-09-18 | 2014-02-11 | Aviex Technologies, Llc | Live bacterial vaccines resistant to carbon dioxide (CO2), acidic PH and/or osmolarity for viral infection prophylaxis or treatment |
| WO2010045620A1 (en) | 2008-10-17 | 2010-04-22 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Recombinant bacterium capable of eliciting an immune response against streptococcus pneumoniae |
| US8241623B1 (en) | 2009-02-09 | 2012-08-14 | David Bermudes | Protease sensitivity expression system |
| RU2507253C2 (ru) | 2009-03-27 | 2014-02-20 | Айдгенозише Технише Хохшуле Цюрих | Презентируемый в salmonella enterica n-гликан из c. jejuni и его производные |
| US9163219B2 (en) * | 2009-04-14 | 2015-10-20 | Arizona Board Of Regents On Behalf Of Arizona State University | Single expression vector for generation of a virus with a segmented genome |
| GB2483595B (en) | 2009-05-22 | 2017-03-29 | The Arizona Board Of Regents For And On Behalf Of Arizona State Univ | Recombinant bacterium and methods of antigen and nucleic acid delivery |
| US9045742B2 (en) * | 2009-05-29 | 2015-06-02 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Recombinant Edwardsiella bacterium |
| US9062297B2 (en) | 2010-01-13 | 2015-06-23 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Yersinia pestis vaccine |
| EP2526185A4 (en) | 2010-01-22 | 2013-07-24 | Univ Arizona | BACTERIUM WITH REGULATED RFAH NUCLEIC ACID |
| US9597379B1 (en) | 2010-02-09 | 2017-03-21 | David Gordon Bermudes | Protease inhibitor combination with therapeutic proteins including antibodies |
| US8771669B1 (en) | 2010-02-09 | 2014-07-08 | David Gordon Bermudes | Immunization and/or treatment of parasites and infectious agents by live bacteria |
| US8524220B1 (en) | 2010-02-09 | 2013-09-03 | David Gordon Bermudes | Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria |
| WO2011150421A2 (en) | 2010-05-28 | 2011-12-01 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Recombinant bacterium to decrease tumor growth |
| CN101920011A (zh) * | 2010-06-29 | 2010-12-22 | 西北农林科技大学 | 表达ibdv免疫原基因的重组减毒鼠伤寒沙门氏菌载体疫苗及其制备方法 |
| US9303264B2 (en) | 2012-05-18 | 2016-04-05 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Photosynthetic microorganisms expressing thermostable lipase |
| KR20210018542A (ko) | 2012-09-06 | 2021-02-17 | 에벨리큐어 바이오테크놀로지스 게엠베하 | 신규의 약독화된 시겔라 생백신 |
| WO2014043838A1 (zh) * | 2012-09-24 | 2014-03-27 | 河北科星药业有限公司 | 预防禽类大肠杆菌病的广谱菌苗的制备方法 |
| CN103055310B (zh) * | 2013-02-04 | 2014-01-08 | 齐鲁动物保健品有限公司 | 一种禽流感（h9 亚型）、大肠埃希氏菌病二联灭活疫苗及其制备方法 |
| US9593339B1 (en) | 2013-02-14 | 2017-03-14 | David Gordon Bermudes | Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatment |
| US9580718B2 (en) | 2013-06-17 | 2017-02-28 | Arizona Board Of Regents On Behalf Of Arizona State University | Attenuated live bacteria with increased acid resistance and methods of use thereof |
| US9868769B2 (en) | 2014-01-06 | 2018-01-16 | The United States Of America, As Represented By The Secretary Of Agriculture | Mutated Salmonella enteriaca |
| KR101660294B1 (ko) * | 2014-01-08 | 2016-09-27 | 전남대학교 산학협력단 | glmS 기반의 숙주 벡터 시스템 |
| US9737592B1 (en) | 2014-02-14 | 2017-08-22 | David Gordon Bermudes | Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment |
| US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| CN105132350B (zh) * | 2015-09-30 | 2018-03-16 | 四川农业大学 | 一种减毒鼠伤寒沙门氏菌的构建方法及其所得菌株和应用 |
| CN105483048A (zh) * | 2015-12-31 | 2016-04-13 | 扬州大学 | 鸡白痢沙门菌spiC-rfaI双基因敲除减毒株及其DIVA疫苗应用 |
| CN105524862A (zh) * | 2015-12-31 | 2016-04-27 | 扬州大学 | 鸡白痢沙门菌spiC-rfaJ双基因敲除减毒株及其DIVA疫苗应用 |
| CN105483051A (zh) * | 2015-12-31 | 2016-04-13 | 扬州大学 | 鸡白痢沙门菌spiC-rfaL双基因敲除减毒株及其DIVA疫苗应用 |
| CN105483052A (zh) * | 2015-12-31 | 2016-04-13 | 扬州大学 | 鸡白痢沙门菌spiC-rfc双基因敲除减毒株及其DIVA疫苗应用 |
| CN105483049A (zh) * | 2015-12-31 | 2016-04-13 | 扬州大学 | 鸡白痢沙门菌spiC-rfaH双基因敲除减毒株及其DIVA疫苗应用 |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| CN106520654B (zh) * | 2016-12-12 | 2019-11-26 | 扬州大学 | 一种基于fur基因的猪霍乱沙门氏菌减毒载体菌及其构建方法 |
| CN110520153B (zh) * | 2017-01-27 | 2024-04-02 | 佛罗里达大学研究基金公司 | 在禽类中控制肠道沙门氏菌和减少弯曲杆菌的食品安全疫苗 |
| EP4132478A1 (en) | 2020-04-09 | 2023-02-15 | Finncure Oy | Mimetic nanoparticles for preventing the spreading and lowering the infection rate of novel coronaviruses |
| US12194157B2 (en) | 2020-04-09 | 2025-01-14 | Finncure Oy | Carrier for targeted delivery to a host |
| CN117305155B (zh) * | 2023-08-28 | 2024-07-05 | 江苏省家禽科学研究所 | 一种抑制沙门氏菌毒力因子的方法 |
| WO2025199081A1 (en) * | 2024-03-21 | 2025-09-25 | Huvepharma Inc. | Recombinant attenuated salmonella vaccines (rasvs) against infections by avian pathogenic escherichia coli (apec) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5110588A (en) | 1986-08-19 | 1992-05-05 | Enterovax Limited | Composite salmonella E. coli, Vibrio cholerae vaccine strains |
| DE3871489D1 (de) | 1987-10-26 | 1992-07-02 | Akzo Nv | Impfstoff gegen e.coli-blutvergiftung bei gefluegel. |
| ATE155690T1 (de) | 1992-04-10 | 1997-08-15 | Schweiz Serum & Impfinst | Rekombinanter lebender impfstoff gegen gram- negative enterische pathogene |
| GR950300072T1 (en) | 1995-10-13 | 1996-01-31 | Schweiz Serum & Impfinst | Recombinant live vaccines against Gram-negative enteric pathogens |
-
1998
- 1998-07-24 US US09/122,441 patent/US6399074B1/en not_active Expired - Fee Related
-
1999
- 1999-07-13 AU AU49914/99A patent/AU4991499A/en not_active Abandoned
- 1999-07-13 JP JP2000560912A patent/JP2002521345A/ja active Pending
- 1999-07-13 MX MXPA01000884A patent/MXPA01000884A/es not_active Application Discontinuation
- 1999-07-13 CN CN99810045A patent/CN1315871A/zh active Pending
- 1999-07-13 WO PCT/US1999/015842 patent/WO2000004919A2/en not_active Ceased
- 1999-07-13 CA CA002338555A patent/CA2338555A1/en not_active Abandoned
- 1999-07-13 EP EP99933977A patent/EP1100536A2/en not_active Withdrawn
- 1999-07-13 BR BR9912410-6A patent/BR9912410A/pt not_active IP Right Cessation
-
2001
- 2001-02-05 ZA ZA200100976A patent/ZA200100976B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000004919A3 (en) | 2000-04-27 |
| JP2002521345A (ja) | 2002-07-16 |
| US6399074B1 (en) | 2002-06-04 |
| BR9912410A (pt) | 2002-01-15 |
| CN1315871A (zh) | 2001-10-03 |
| WO2000004919A2 (en) | 2000-02-03 |
| AU4991499A (en) | 2000-02-14 |
| CA2338555A1 (en) | 2000-02-03 |
| MXPA01000884A (es) | 2002-06-04 |
| EP1100536A2 (en) | 2001-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200100976B (en) | Live attenuated salmonella vaccines to control avian pathogens. | |
| GB9711964D0 (en) | Live attenuated vaccines | |
| HUP9902790A3 (en) | Avian polynucleotide vaccine formula | |
| ZA200205329B (en) | High meat pet food composition. | |
| ZA9711247B (en) | Recombinant live avian vaccine using as vector the avian infectious laryngotracheitis virus | |
| ZA975618B (en) | Avian recombinant live vaccine using as vector the avian infectious laryngotrachetis virus | |
| IL137872A0 (en) | Live recombined vaccines injected with adjutant | |
| NO2010011I1 (no) | Levende svekket humant rotavirus stamme Rix 4414 (Rotavirus vaksine) | |
| AU6231501A (en) | Foodstuff for pets or other animals | |
| PT1403375E (pt) | Vacina viva recombinante aviária, utilizando como vector um vírus de herpes aviário | |
| GB0122811D0 (en) | Atmospheric steamer | |
| AU7105598A (en) | Attenuated, invasive vaccines against fish pathogens | |
| DK1267899T3 (da) | ssa-inaktiverede salmonellavacciner | |
| ZA9710130B (en) | Attenuated live neospora vaccine | |
| HUP0302612A3 (en) | Salmonella vaccine | |
| HUP0005010A2 (en) | Salmonella vaccine | |
| GB2361670B (en) | Printing techniques to hide swath boundary banding | |
| ZA9610102B (en) | Salmonella vaccines. | |
| AU2144499A (en) | Live attenuated salmonella vaccine | |
| ZA974809B (en) | Live attenuated RTX-producing bacteria of the family pasteurellaceae. | |
| DE69615656D1 (de) | Aviären infektiösen anämie mastgeflügel impfstoff | |
| MX9205677A (es) | Planta de tratamiento de aire para productos alimenticios. | |
| ATE240118T1 (de) | Salmonella typhi impfstoffzusammensetzungen | |
| AU4489896A (en) | Avian recombinant live vaccine | |
| IT1319684B1 (it) | Prodotti alimentari fitoterapici. |